242 filings
Page 10 of 13
8-K
bsyff87 e8cjoknac0p
28 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
gtc1q 4dgm9lurx
16 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
fye6a h76aqivz78zz1
22 Jan 18
Results of Operations and Financial Condition
12:00am
8-K
mb4lyapk 8w2xbt8e
18 Jan 18
Regulation FD Disclosure
12:00am
8-K
ly0vlc04v f0hh
2 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
hyavwojrh5xobsa
18 Dec 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
i4kgbej
14 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
dhytpr hfg704yk
14 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
ul1wej 6okvpy
1 Dec 17
Regulation FD Disclosure
12:00am
8-K
y7fk15 j205pcm77wqv
27 Nov 17
Other Events
12:00am
8-K
2wwdrpot
24 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
wt9wo144w 4q8
24 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
34an2pq0l5sdzk
20 Nov 17
Jaguar Health Files First Quarterly Earnings Report Since July 2017 Merger with Napo Pharmaceuticals
12:00am
8-K
5xukvkx
14 Nov 17
Results of Operations and Financial Condition
12:00am
8-K
u1dt2ffslvxzvwn
9 Nov 17
Regulation FD Disclosure
12:00am
8-K
cy01o3am7d dv
7 Nov 17
Termination of a Material Definitive Agreement
12:00am
8-K
o84urd
26 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
e7g8dnxeudf
3 Oct 17
Jaguar Health Prices $4.25 Million Public Offering of Common Stock
12:00am
8-K
70sgij v1
25 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
79z 6wynwwv
15 Sep 17
Jaguar Health Subsidiary Napo Pharmaceuticals Expands Mytesi Salesforce with Hire of Experienced HIV & GI Drug Sales Reps in Key U.S. Markets
12:00am